Abstract
A series of thiadiazole derivatives has been designed as potential allosteric, substrate competitive inhibitors of the protein kinase JNK. We report on the synthesis, characterization and evaluation of a series of compounds that resulted in the identification of potent and selective JNK inhibitors targeting its JIP-1 docking site.
Copyright 2009 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Drug Design
-
HeLa Cells
-
Humans
-
JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors*
-
Models, Molecular
-
Molecular Structure
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Structure-Activity Relationship
-
Thiadiazoles / chemical synthesis*
-
Thiadiazoles / chemistry
-
Thiadiazoles / pharmacology*
Substances
-
Protein Kinase Inhibitors
-
Thiadiazoles
-
JNK Mitogen-Activated Protein Kinases